Study shows how blood cells change shape

Millions of times during their four-month lifespan, human red blood cells must squeeze through tiny capillaries to deliver their payload of oxygen and pick up waste carbon dioxide-functions essential to life.

Now, for the first time, MIT researchers have developed a dynamic, molecular-level model that describes how the cells deform their normal disc shape to pass through vessels that are often much narrower than the cells themselves.

Blood cells must rearrange components of their internal scaffolding (so-called cytoskeleton), allowing the cells to become almost liquid-like, in order to squeeze through the narrowest capillaries found in the body, the researchers report in a paper to be published in the March 12 online edition of the Proceedings of the National Academy of Sciences.

Studying the mechanics of how a blood cell can transform from a soft object to an almost fluid-like state will help researchers better understand several types of blood disorders, said Subra Suresh, senior author of the paper and the Ford Professor of Engineering with joint appointments in materials science and engineering, biological engineering, mechanical engineering and health sciences and technology.

"Now we can study how molecular structure affects the shape, which affects the mechanical properties, and both of which affect mobility," he said.

Mobility is a key factor in diseases like malaria and the genetic disorder sickle cell anemia, both of which render red blood cells unable to flow through narrow capillaries.

Red blood cells have a diameter of about eight microns, or millionths of a meter. As they flow through the body, they often encounter blood vessels, such as those in the brain, with a diameter of only about two microns. Each time the cells reach such a vessel, they must stretch into a bullet-like shape to squeeze through and then return to their original disc shape upon exiting the vessel.

The researchers' model shows that reorganization of the cytoskeleton could account for such deformation. Every red blood cell has a cytoskeleton, a sort of scaffolding made of protein molecules called spectrin, attached to the inside of its cell membrane in a brush-like network.

When the bonds within that protein network or between the network and the cell membrane are broken, holes open up in the cytoskeleton, allowing the cell to become more fluidic and squeeze through narrow passages. The researchers show that such a transformation can be achieved by breaking either of two types of cytoskeletal bonds-bonds between two molecules of spectrin or bonds between spectrin and another protein called actin, which is embedded in the cell membrane.

An input of either mechanical energy (such as squeezing or shearing) or chemical energy (such as ATP, an energy carrier used by cells), is enough to break those bonds and cause the necessary cytoskeleton deformation, according to Suresh. In the future, the researchers plan to study how the interplay of those types of energy inputs affects the cells.

The new model could also be used to study several types of blood disorders, including malaria, as the cell membrane and cytoskeleton are altered by the presence of the parasite inside the cell.

In earlier work, Suresh and colleagues showed that as malaria infection progresses, red blood cells become less deformable, which explains why it is harder for them to squeeze through narrow vessels. Using the new model, researchers can study how the infection affects the blood cells on a molecular level to make them less deformable.

Other diseases that could be studied are the genetic disorders sickle cell anemia and spherocytosis. In patients with sickle cell anemia, red blood cells take on a sickle shape that prevents them from flowing through blood vessels. Spherocytosis causes red blood cells to become spherical so they can't deform properly to get through small capillaries.

The lead author on the PNAS paper is Ju Li, a former MIT graduate student and assistant professor at Ohio State University. Other authors are George Lykotrafitis, a postdoctoral associate in MIT's Department of Materials Science and Engineering (MSE), and Ming Dao, an MIT research scientist in MSE.

Source: MIT

Related stories:

Stem cells can be used to create limitless blood supplies: paper
Scientists from a US firm claim to have created a large number of red blood cells from human embryonic stem cells, opening up the prospect of having a limitless supply of blood for transfusions.
Researcher develops novel method to grow human embryonic stem cells
(PhysOrg.com) -- The majority of researchers working with human embryonic stem cells (hESCs) – cells which produce any type of specialized adult cells in the human body – use animal-based materials for culturing the cells. But because these materials are animal-based, they could transmit viruses and other pathogens to the hESCs, making the cells unsuitable for medical use.
Biomarkers reveal our biological age
(PhysOrg.com) -- Not a day passes when we don’t get a little bit older. However, the exact processes involved in human aging are still puzzling. Scientists working with Lenhard Rudolph and Hong Jiang from the Max Planck Research Group for Stem Cell Aging in Ulm have now identified a group of proteins that reveal the biological age of a person. These biomarkers could be used in medicine to adapt therapies for older people to their individual biological age (PNAS, August 12, 2008).
Stem cell advance may help transfusion supplies
(AP) -- Scientists say they've found an efficient way to make red blood cells from human embryonic stem cells, a possible step toward making transfusion supplies in the laboratory.
Limbs saved by menstrual blood stem cells
Cells obtained from menstrual blood, termed 'endometrial regenerative cells' (ERCs) are capable of restoring blood flow in an animal model of advanced peripheral artery disease. A study published today in BioMed Central's open access Journal of Translational Medicine demonstrates that when circulation-blocked mice were treated with ERC injections, circulation and functionality were restored.
Chemical liberated by leaky gut may allow HIV to infect the brain
In up to 20 percent of people infected with HIV, the virus manages to escape from the bloodstream and cross into the brain, resulting in HIV-associated dementia and other cognitive disorders. Now, scientists at the Albert Einstein College of Medicine of Yeshiva University have found strong evidence that a component of the cell walls of intestinal bacteria—a chemical present in high levels in the blood of HIV-infected people—helps HIV to penetrate the usually-impregnable blood brain barrier (BBB). The findings, published in the August issue of the Journal of Virology, could lead to strategies for preventing HIV from entering the brain and causing serious complications.
Scientists discover what drives the development of a fatal form of malaria
Platelets – those tiny, unassuming cells that cause blood to clot and scabs to form when you cut yourself – play an important early role in promoting cerebral malaria, an often lethal complication that occurs mostly in children. Affecting as many as half a billion people in tropical and subtropical regions, malaria is one of the oldest recorded diseases and the parasite responsible for it, Plasmodium, among the most studied pathogens of all time. Still, cerebral malaria, which results from a combination of blood vessel and immune system dysfunction, is not well understood.
1918 flu antibodies resurrected from elderly survivors
Ninety years after the sweeping destruction of the 1918 flu pandemic, researchers at Monroe Carell Jr. Children's Hospital at Vanderbilt have recovered antibodies to the virus – from elderly survivors of the original outbreak.

News discussion:

General Science news